$23M sweet spot round size
Most of their 66 investments are in rounds between $12M and $34M
2001
IpiNovyx Bio raised $10M on October 5, 2021
Investors: Pathway Bioventures, Generation Ventures, Viva BioInnovator and Lilly Ventures
Evox Therapeutics Ltd raised $10M on June 9, 2020
Investors: Lilly Ventures
Kymera Therapeutics raised $65M on November 13, 2018
Investors: 6 Dimensions Capital, Sanofi Ventures, Bessemer Venture Partners, AJU IB INVESTMENT, Atlas Ventures and Lilly Ventures
Sutro Biopharma, Inc. raised $85M on July 26, 2018
Investors: Nexthera Capital, Tekla Capital Management, Samsara BioCapital, Surveyor Capital, Vida Ventures, LLC, Sky Ventures, SV Life Sciences and Lilly Ventures
Undisclosed raised $65M on June 5, 2018
Investors: S.R. One Ltd, Atlas Venture, Lightstone Ventures and Lilly Ventures
Kymera Therapeutics raised $30M on October 30, 2017
Investors: Atlas Venture and Lilly Ventures
Cavion, Inc. raised $26M on January 6, 2017
Investors: Lilly Ventures
Symic Biomedical raised $25M on December 1, 2015
Investors: Lilly Ventures
Protagonist Therapeutics raised $40M on July 16, 2015
Investors: Adage Capital Management, Canaan, Inbio Ventures, RA Capital Management, L.P., Foresite Capital, Starfish Ventures and Lilly Ventures
Aeglea BioTherapeutics raised $44M on March 23, 2015
Investors: Jennison Associates LLC, UT Horizon Fund, OrbiMed Advisors, RA Capital Management, L.P., New Ground Ventures, Venrock and Lilly Ventures